Belden Inc
F:QCTA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Belden Inc
F:QCTA
|
US |
|
Research Solutions Inc
F:61I
|
US |
|
Nanobiotix SA
F:5NR
|
FR |
|
Telix Pharmaceuticals Ltd
F:T3X
|
AU |
|
Perma-Pipe International Holdings Inc
F:MF3
|
US |
Wall St Price Targets
QCTA Price Targets Summary
Belden Inc
According to Wall Street analysts, the average 1-year price target for QCTA is 141.46 EUR with a low forecast of 139.14 EUR and a high forecast of 147.55 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is QCTA's stock price target?
Price Target
141.46
EUR
According to Wall Street analysts, the average 1-year price target for QCTA is 141.46 EUR with a low forecast of 139.14 EUR and a high forecast of 147.55 EUR.
What is the Revenue forecast for Belden Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Belden Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 3 years is 15%.
What is the Net Income forecast for Belden Inc?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 16%.
